tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Cresco Labs Launches US$100 Million At-the-Market Equity Program

Story Highlights
  • Cresco Labs set up a US$100 million at-the-market share offering in Canada.
  • The ATM facility gives flexible funding for general needs and acquisitions, aligned with disciplined capital allocation.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Cresco Labs Launches US$100 Million At-the-Market Equity Program

Claim 50% Off TipRanks Premium

An announcement from Cresco Labs ( (TSE:CL) ) is now available.

Cresco Labs has established an at-the-market (ATM) equity offering program that will allow it to issue and sell up to approximately US$100 million (C$140 million) of subordinate voting shares from time to time through Haywood Securities on Canadian marketplaces. Management says the program adds flexible, opportunistic access to capital to support general corporate purposes and potential acquisitions, with any use of the facility guided by market conditions, the company’s valuation and the availability of accretive opportunities that can enhance profitability and strengthen the balance sheet, underscoring a disciplined capital allocation approach as the cannabis sector matures and regulatory reform advances.

The most recent analyst rating on (TSE:CL) stock is a Hold with a C$1.50 price target. To see the full list of analyst forecasts on Cresco Labs stock, see the TSE:CL Stock Forecast page.

Spark’s Take on TSE:CL Stock

According to Spark, TipRanks’ AI Analyst, TSE:CL is a Neutral.

Cresco Labs’ overall stock score is primarily impacted by its financial performance challenges, including declining revenues and high leverage. Technical analysis shows moderate strength, while valuation remains weak due to negative profitability metrics. The earnings call provided some positive insights into strategic expansions and debt refinancing, but ongoing market challenges and operational adjustments weigh on the outlook.

To see Spark’s full report on TSE:CL stock, click here.

More about Cresco Labs

Cresco Labs Inc. is a U.S.-based cannabis company focused on branded consumer packaged goods and retail, operating the Sunnyside dispensary chain and a portfolio of popular cannabis brands. The company positions itself as a leader in cultivation, production and branded product distribution, aiming to normalize and professionalize the cannabis industry through a CPG-driven brand strategy, customer-focused retail, and active engagement on legislative and regulatory issues.

Average Trading Volume: 357,601

Technical Sentiment Signal: Sell

Current Market Cap: C$654M

Learn more about CL stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1